Avience Biomedicals Ltd vs Credent Connect N Care Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Avience Biomedicals Ltd is ₹ 240 as of 23 Oct 15:30 . The P/E Ratio of Avience Biomedicals Ltd is 0 as of March 2024 .The P/E Ratio of Credent Connect N Care Ltd is 0 as of March 2024 . The Market Cap of Avience Biomedicals Ltd is ₹ 0 crore as of March 2024 .The Market Cap of Credent Connect N Care Ltd is ₹ 0 crore as of March 2024 . The Dividend Payout of Avience Biomedicals Ltd changed from 0 % on March 2022 to 0 % on March 2026 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Credent Connect N Care Ltd changed from 0 % on March 2022 to 0 % on March 2026 . This represents a CAGR of 0.0% over 5 years .

About Avience Biomedicals Ltd

Avience Biomedicals Limited was originally incorporated as Private Limited Company as 'Avience Biomedicals Private Limited' on December 23, 2019 with the Registrar of Companies, Delhi.
Later, Company's status got converted into a Public Limited Company, the name of the Company was changed to 'Avience Biomedicals Limited' and fresh Certificate of incorporation dated September 3, 2024, was issued by the Registrar of Companies, Delhi. Avience Biomedicals Limited is a medical consumable company dedicated to manufacturing of Vitro-Diagnostic (IVD) products and medical devices in Noida, Uttar Pradesh, India.
In vitro diagnostics (IVDs) are tests that can detect disease, conditions and infections. The Company commenced its journey by producing essential diagnostic kits like Viral Transport Media (VTM), Covid, Human Immunodeficiency Viruses (HIV), HBs AG, Malaria, Dengue and others aimed at aiding medical institutions with affordable and good-quality solutions.

About Credent Connect N Care Ltd

Credent Connect N Care Limited was originally incorporated as a Private Company under the name of 'Credent Cold Chain Logistics Private Limited' on June 25, 2015 with the Registrar of Companies, Delhi.
Thereafter, the name of the Company was changed to 'Credent Connect N Care Private Limited' vide certified dated May 10, 2024.
Further, pursuant to a Special Resolution passed by the shareholder, the Company converted from Private Limited into Public limited and name of the Company has changed from 'Credent Connect N Care Private Limited' to 'Credent Connect N Care Limited' dated October 28, 2025. The Company is a healthcare services provider engaged in delivering integrated logistics, workforce solutions, and technology-enabled support to healthcare institutions across India.
It provide complete operational and logistics services to diagnostic laboratories, In Vitro Diagnostics (IVD) companies, pharmaceutical companies, clinics, and other healthcare enterprises through end-to-end solutions.

FAQs for the comparison of Avience Biomedicals Ltd and null

Which company has a larger market capitalization, Avience Biomedicals Ltd or Credent Connect N Care Ltd?

Market cap of Avience Biomedicals Ltd is 131 Cr while Market cap of Credent Connect N Care Ltd is 572 Cr

What are the key factors driving the stock performance of Avience Biomedicals Ltd and Credent Connect N Care Ltd?

The stock performance of Avience Biomedicals Ltd and Credent Connect N Care Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Avience Biomedicals Ltd and Credent Connect N Care Ltd?

As of October 25, 2026, the Avience Biomedicals Ltd stock price is INR ₹240.0. On the other hand, Credent Connect N Care Ltd stock price is INR ₹313.9.

How do dividend payouts of Avience Biomedicals Ltd and Credent Connect N Care Ltd compare?

To compare the dividend payouts of Avience Biomedicals Ltd and Credent Connect N Care Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.